Quantcast

Garden State Times

Wednesday, October 16, 2024

New Jersey: Biologics companies were the second most FDA inspected companies in New Jersey in July

Webp guy3yrvoyjza3x92utpmthz4c774

Suzanne Roosen Acting Director of the Office of Food Policy and Response (OFPR) | Official Website

Suzanne Roosen Acting Director of the Office of Food Policy and Response (OFPR) | Official Website

In July, two Biologics companies received two FDA inspections in New Jersey, according to the U.S. Food and Drug Administration (FDA).

This was the second highest number of inspections per type of company made by the FDA in New Jersey, equalling 15.4% of all inspections in July.

Of all the New Jersey companies involved in Biologics, North Hudson IVF Center for Fertility & Gynecology, P.C. received the most citations from the FDA in July.

The FDA routinely inspects facilities across the nation to determine if the workplaces and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly for businesses to consistently make smarter business decisions for the future.

The FDA is a government agency primarily responsible for monitoring the manufacturing and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.

FDA Inspections in New Jersey During July
Project AreaNo Action IndicatedVoluntary Action IndicatedOfficial Action Indicated
Blood and Blood Products--1--
Drug Quality Assurance--1--
Food Composition, Standards, Labeling and Econ1----
Foodborne Biological Hazards73--
Human Cellular, Tissue, and Gene Therapies11--

ORGANIZATIONS IN THIS STORY

!RECEIVE ALERTS

The next time we write about any of these orgs, we’ll email you a link to the story. You may edit your settings or unsubscribe at any time.
Sign-up

DONATE

Help support the Metric Media Foundation's mission to restore community based news.
Donate

MORE NEWS